FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Moves to Reevaluate Several Peptides American Med Spa Association Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review